Aerie Pharmaceuticals (AERI)

Aerie Pharma (AERI) Stock Price & Analysis


AERI Stock Chart & Stats

Day’s Range$15.24 - $15.25
52-Week Range― - ―
Previous Close$15.24
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding49,417,407
10 Day Avg. Volume121,518
30 Day Avg. Volume362,501
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)-4.60
Price to Sales (P/S)3.52
Price to Cash Flow (P/CF)100.90
P/FCF Ratio285.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Aerie Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Aerie Pharmaceuticals’s market cap?
Currently, no data Available
When is Aerie Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aerie Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Aerie Pharmaceuticals overvalued?
According to Wall Street analysts Aerie Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Aerie Pharmaceuticals pay dividends?
    Aerie Pharmaceuticals does not currently pay dividends.
    What is Aerie Pharmaceuticals’s EPS estimate?
    Aerie Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Aerie Pharmaceuticals have?
    Currently, no data Available
    What happened to Aerie Pharmaceuticals’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Aerie Pharmaceuticals?
    Among the largest hedge funds holding Aerie Pharmaceuticals’s share is Deerfield Management Company, LP. It holds Aerie Pharmaceuticals’s shares valued at 73M.


      Aerie Pharma Stock Smart Score

      The Aerie Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
      Learn more about TipRanks Smart Score

      Company Description

      Aerie Pharmaceuticals

      Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Belite Bio, Inc. ADR
      Provention Bio
      Amneal Pharmaceuticals

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis